200
Participants
Start Date
June 27, 2017
Primary Completion Date
December 20, 2022
Study Completion Date
December 31, 2022
Qualitative Interview or Focus group discussions
"The purpose of this study is to identify factors that influence decision-making in treatment selection and the optimal approach for sharing information about prognosis and guideline-based care.~Secondly, to further understand patient perspective on the concept of de-escalation, in which patients reduce the amount of chemotherapy to avoid side effects and (2) consider how prognosis would impact their decision-making about reducing chemotherapy (as standard or care or within a clinical trial)."
University of Alabama at Birmingham, Birmingham
American Cancer Society, Inc.
OTHER
University of Alabama at Birmingham
OTHER